Liraglutide Peptide: The Complete Guide - Uses, Mechanism, Dosing, Safety & Research
Liraglutide is a synthetic peptide analog of human glucagon-like peptide-1 (GLP-1), a hormone naturally released after eating to stimulate insulin secretion, suppress glucagon, and signal fullness to the brain. It is FDA-approved under two brand names - Victoza for type 2 diabetes and cardiovascular risk reduction, and Saxenda for chronic weight management - and is one of the most extensively studied peptide compounds in clinical medicine. This guide covers what liraglutide does, how it works at a molecular level, what the major clinical trials found, dosing context, safety considerations, regulatory status, and how it compares to semaglutide and other GLP-1 alternatives.